Oakman looks to raise £5.3m from shareholders

Oakman Group's CEO, Dermot King & Exec Chairman Peter Borg-Neal - med res

The discounted share placement will provide a buffer to protect the business from a further worsening of the trading environment

 

THIS ARTICLE IS ONLY AVAILABLE TO SUBCRIBERS

Already have an account? SIGN IN HERE

Gated access promo

Create your free MCA account to get instant access to this article.

Learn more about MCA here

Alternatively SUBSCRIBE for unrestricted access to all content. Contact us for more information